H.R.1629: Fairness in Orphan Drug Exclusivity Act

About This Bill

Bill Cosponsors

2 (1 Democrat, 1 Republican)

Bill Versions

Bill Summary

Fairness in Orphan Drug Exclusivity Act This bill limits which orphan drugs may be granted a market exclusivity period by the Food and Drug Administration (FDA). (Generally, an orphan drug is one that is not economically viable because of the rarity of the disease that it treats. The sponsor of an FDA-designated orphan drug may be granted various incentives, such as a seven-year period in which the FDA may not grant market approval to a...

(Source: Library of Congress)

Statement of Administration Policy

The administration this legislation.

What Lawmakers Are Saying About This Bill

There are 8 statements associated with H.R.1629.

Bill Actions

Date Description
May 20, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 19, 2021
On passage Passed by the Yeas and Nays: 402 - 23 (Roll no. 150).
May 19, 2021
Considered as unfinished business.
May 19, 2021
Considered under the provisions of rule H. Res. 403.
May 19, 2021
Motion to reconsider laid on the table Agreed to without objection.
May 19, 2021
POSTPONED PROCEEDINGS - At the conclusion of debate on H.R. 1629, the Chair put the question on passage and by voice vote, announced that the ayes had prevailed. Mrs. Greene (GA) demanded the yeas and nays and the Chair postponed further proceedings on the question of passage until a time to be announced.
May 19, 2021
The previous question was ordered pursuant to the rule.
May 19, 2021
DEBATE - The House proceeded with one hour of debate on H.R. 1629.
May 19, 2021
Rule provides for consideration of H.R. 1629 and H. Res. 275. The resolution provides for consideration of H.R. 1629 under a closed rule and H. Res. 275 under a closed rule. The resolution provides for one hour of debate on both the bill and resolution. The rule provides that H. Res. 398 is hereby adopted. The rule provides at any time through the legislative day of Thursday, May 20, 2021, the Speaker may entertain motions offered by the Majority Leader or designee with respect to multiple measures that were object of motions to suspend the rules on the legislative days of May 17 or 18, 2021.
May 19, 2021
On passage Passed by the Yeas and Nays: 402 - 23 (Roll no. 150). (text: CR H2561)
May 19, 2021
Considered as unfinished business. (consideration: CR H2572-2573)
May 19, 2021
Considered under the provisions of rule H. Res. 403. (consideration: CR H2560-2563)
May 17, 2021
Rules Committee Resolution H. Res. 403 Reported to House. Rule provides for consideration of H.R. 1629 and H. Res. 275. The resolution provides for consideration of H.R. 1629 under a closed rule and H. Res. 275 under a closed rule. The resolution provides for one hour of debate on both the bill and resolution. The rule provides that H. Res. 398 is hereby adopted. The rule provides at any time through the legislative day of Thursday, May 20, 2021, the Speaker may entertain motions offered by the Majority Leader or designee with respect to multiple measures that were object of motions to suspend the rules on the legislative days of May 17 or 18, 2021.
May 11, 2021
On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 250 - 168 (Roll no. 134).
May 11, 2021
Considered as unfinished business. (consideration: CR H2184-2185)
May 11, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
May 11, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 1629.
May 11, 2021
Considered under suspension of the rules. (consideration: CR H2181-2183; text: CR H2181-2182)
May 11, 2021
Mr. Pallone moved to suspend the rules and pass the bill.
March 9, 2021
Referred to the Subcommittee on Health.
March 8, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
March 8, 2021

Introduced in the House by Madeleine Dean (D-Pa.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page